Renewable products company, Amyris (AMRS), once stood on the top pedestal of the ongoing revolution in industrial biotechnology. By applying its synthetic biology platform to convert sugar into a variety of molecules, the company was on the cutting edge of creating the chemical building blocks needed to replace a wide range of petroleum-sourced products. In using genetically modified yeast, Amyris quickly proved the feasibility of its tiny microbial factories.
Early on in its corporate history, Amyris was awarded a 5-year, $42.6 million grant from the Bill and Melinda Gates Foundation via OneWorld Health. The grant was used for research into the synthetic creation of artemisinic acid. Artemisinic acid serves as a precursor to the creation of...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|